- Home
- GLRE vs MLAB Comparison
GLRE vs MLAB Comparison
Compare GLRE & MLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLRE
- MLAB
- Stock Information
- Founded
- GLRE 2004
- MLAB 1982
- Country
- GLRE Cayman Islands
- MLAB United States
- Employees
- GLRE N/A
- MLAB N/A
- Industry
- GLRE Property-Casualty Insurers
- MLAB Industrial Machinery/Components
- Sector
- GLRE Finance
- MLAB Industrials
- Exchange
- GLRE Nasdaq
- MLAB Nasdaq
- Market Cap
- GLRE 480.7M
- MLAB 524.2M
- IPO Year
- GLRE 2007
- MLAB N/A
- Fundamental
- Price
- GLRE $13.11
- MLAB $68.99
- Analyst Decision
- GLRE
- MLAB Hold
- Analyst Count
- GLRE 0
- MLAB 2
- Target Price
- GLRE N/A
- MLAB $130.00
- AVG Volume (30 Days)
- GLRE 170.4K
- MLAB 227.7K
- Earning Date
- GLRE 08-05-2025
- MLAB 08-05-2025
- Dividend Yield
- GLRE N/A
- MLAB 0.91%
- EPS Growth
- GLRE N/A
- MLAB N/A
- EPS
- GLRE 1.32
- MLAB N/A
- Revenue
- GLRE $717,617,000.00
- MLAB $240,978,000.00
- Revenue This Year
- GLRE N/A
- MLAB $6.45
- Revenue Next Year
- GLRE N/A
- MLAB $5.80
- P/E Ratio
- GLRE $10.10
- MLAB N/A
- Revenue Growth
- GLRE 2.79
- MLAB 11.47
- 52 Week Low
- GLRE $11.95
- MLAB $69.19
- 52 Week High
- GLRE $15.82
- MLAB $155.12
- Technical
- Relative Strength Index (RSI)
- GLRE 34.27
- MLAB 26.23
- Support Level
- GLRE $13.03
- MLAB $76.19
- Resistance Level
- GLRE $14.15
- MLAB $80.93
- Average True Range (ATR)
- GLRE 0.33
- MLAB 5.14
- MACD
- GLRE -0.12
- MLAB -1.66
- Stochastic Oscillator
- GLRE 5.23
- MLAB 3.80
About GLRE Greenlight Capital Re Ltd.
Greenlight Capital Re Ltd offers property and casualty reinsurance. Its customers are property and casualty insurers, and Greenlight takes on some of their risk in exchange for insurance premiums. It operates through one operating segment: property and casualty reinsurance. It generates revenue through premiums from reinsurance on property and casualty business assumed and income from investments.
About MLAB Mesa Laboratories Inc.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.